The stock price of Pharmaniaga and Duopharma Biotech soar when there is positive news on vaccine trials. In addition, both companies are chosen to undertake the fill and finish process once the vaccine is developed. Thus, let’s us share with you the Pharmaniaga and Duophama background.
Pharmaniaga is known as the largest Malaysian pharmaceutical company. It engages in manufacturing, marketing and distribution of pharmaceutical products and medical products. Their revenue has increased in the past 5 years. However, they incurred a loss in 2019.
Have you heard about Citrex? If yes, you are part of Pharmaniaga consumers.
They also have their own community pharmacy chain under the brand of Royale Pharma. Currently, they are located in Bangi Selangor and Bandar Laguna Merbok, Sungai Petani. You can have your health screening here as well.
Pharmaniaga has been recognized as the Company of the Year (Integrated Pharmaceutical Group) at the CSR Malaysia Award 2019 ceremony. The Ministry of Women, Family and Community Development has organised this award ceremony.
Recently, Pharmaniaga has shared its expansion plan in the manufacturing business. It also establishes its presence in Indonesia. Many shareholders are also very keen to discover about its Halal vaccine project.
Alike Pharmaniaga, Duopharma also manufactures,distributes and imports pharmaceutical product and medicine in Malaysia. Some well known-products are Champs, Flavettes, Proviton , Eye Glo, etc. It is the subsidiary of Permodalan Nasional Berhad.
Awards and Recognition
Duopharma is recognized as a member of FTSE4Good Bursa Malaysia Index. Besides, Frost and Sullivan also recognizes Duopharma as Malaysia Halal Pharmaceutical Company of the Year award for its excellent track records. Based on the Nielsen’s Retail Audit Report, Champs and Eye Glo continue to dominate the children’s vitamin C and eye care market in Malaysia.
Strong Financial Growth
Duopharma has a revenue growth for the past 5 years. Meanwhile, its profit for the past 3 years also improves as well. In 2019, Duopharma reported a gain of RM71 mil.
Investment in Digital Health Platform, Naluri
To spur Malaysia’s digital health growth, Duopharma has recently invested in Naluri. Naluri is a local pioneer in digital therapeutics. The Naluri apps recently gain much traction from corporate clients. It has successfully provided a holistic health management programme for its users.
We also shared about the story of 2 billionaires due to the surge in demand for rubber gloves. Check it out!
Source: the edge